🔗 Share this article

Chancellor Rachel Reeves has announced she is preparing "specific action to address household expense issues" in the upcoming financial statement.

Speaking to media outlets, she emphasized that lowering inflation is a shared duty of both the government and the central bank.

The United Kingdom's inflation rate is projected to be the highest among the G7 developed nations this calendar year and the following year.

Potential Utility Cost Measures

Sources suggest the government could intervene to bring down energy bills, for instance by reducing the present 5% level of value-added tax charged on energy supplies.

Another approach is to reduce some of the regulatory levies currently included in bills.

Budgetary Constraints and Analyst Predictions

The administration will receive the next assessment from the official forecaster, the OBR, on the start of the week, which will show how much room there is for these actions.

The view from most analysts is that the Chancellor will have to declare tax increases or spending cuts in order to adhere to her declared borrowing rules.

Earlier on the same day, calculations suggested there was a twenty-two billion pound shortfall for the Treasury chief to resolve, which is at the more modest range of projections.

"It is a joint responsibility between the Bank of England and the administration to further reduce some of the sources of inflation," Reeves told reporters in Washington, at the conferences of the International Monetary Fund and World Bank.

Revenue Commitments and International Concerns

While a great deal of the attention has been on expected tax rises, the chancellor said the most recent figures from the fiscal watchdog had not changed her pledge to election pledges not to increase rates on income tax, VAT or National Insurance.

She attributed an "unpredictable global environment" with growing international and commercial issues for the Budget revenue measures, likely to be targeted on those "with the broadest shoulders."

International Economic Tensions

Addressing concerns about the United Kingdom's economic relations with China she said: "Our national security always are paramount."

Last week's statement by China to increase export controls on rare earths and other materials that are key for advanced tech production led US President Donald Trump to threaten an extra 100% tariff on imports from the Asian country, increasing the risk of an full-scale commercial conflict between the two largest economies.

The American finance chief labeled the Chinese decision "economic coercion" and "a global supply chain control attempt."

Inquired about accepting the American proposal to join its conflict with the Asian nation, Reeves said she was "very concerned" by Chinese measures and encouraged the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "damaging for the international commerce and causes additional challenges."

"In my view there are sectors where we must challenge Chinese policies, but there are also valuable opportunities to trade with Chinese markets, including banking sector and other sectors of the economy. We've got to get that equilibrium right."

The Treasury chief also confirmed she was working with international partners "on our own critical minerals plan, so that we are more independent."

Health Service Medicine Pricing and Funding

Reeves also admitted that the cost the National Health Service pays for drugs could rise as a result of current talks with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and capital.

Some of the biggest global drug companies have said lately that they are either delaying or scrapping projects in the UK, with several attributing the modest returns they are receiving.

Recently, the Science Minister said the cost the health service spends on drugs would need to go up to stop firms and drug research funding leaving the United Kingdom.

Reeves informed media: "We have seen due to the payment system, that clinical trials, recent pharmaceuticals have not been available in the United Kingdom in the manner that they are in other European countries."

"The objective is to guarantee that people getting treatment from the National Health Service are can access the top critical medicines in the world. And so we are reviewing all of that, and... looking to attract more capital into the UK."